Ben-Maimon Carole
- SEC CIK
- 0001529611
No open-market purchases or sales filed in the past year.
Current role at each company
- LRMR Larimar Therapeutics, Inc.President and CEOas of Jan 27, 2026
- Teligent, Inc.Directoras of Jul 22, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ben-Maimon Carole as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LRMR Larimar Therapeutics, Inc.
President and CEO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2023 (view filing) | May 17 | 1 day | Ben-Maimon CarolePresident and CEO | PPurchase | +5.00K | $3.71 | +$18.6K | +1.9%266.8K after | |
| Sep 19, 2022 (view filing) | Sep 16 | 3 days | Ben-Maimon CarolePresident and CEO | PPurchase | +31.7K | $3.15 | +$100.0K | +126.6%56.8K after |